Vorier 200mg – Composition, Uses and Medicine Enquiries
Product Overview
Vorier 200mg is a product listed under the systemic antifungal medicine category and is classified as a triazole antifungal.
Its active composition is Voriconazole 200 mg.
It is associated with serious invasive fungal infections, including invasive aspergillosis.
The active ingredient inhibits fungal ergosterol synthesis, damaging the fungal cell membrane.
Suitability depends on the diagnosis, approved labeling, clinical history and specialist assessment.
This information is provided for education and product identification, not as a recommendation to begin treatment.
Monitoring of liver function, visual effects, photosensitivity and numerous medicine interactions is important.
A qualified clinician should confirm whether this exact brand, strength and formulation are appropriate before any prescription or treatment decision.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Voriconazole | 200 mg |
Product Name: Vorier 200mg
Generic Name: Voriconazole
Brand Name: Vorier
Strength: 200 mg
Please verify the exact strength, dosage form and manufacturer details against the original product packaging before publishing this product page or proceeding with an enquiry.
The exact oral tablet presentation must be verified. An injectable formulation is a different product.
Therapeutic Category and Indication
Vorier 200mg belongs to the systemic antifungal medicine category and is classified as a triazole antifungal.
Its clinical use relates to serious invasive fungal infections, including invasive aspergillosis.
The active ingredient inhibits fungal ergosterol synthesis, damaging the fungal cell membrane.
Treatment eligibility may depend on diagnostic tests, organ function, other medicines and the relevant national prescribing information.
Monitoring of liver function, visual effects, photosensitivity and numerous medicine interactions is important.
The exact approved uses and restrictions should be checked against the current local prescribing information.
Administration Information
For the verified oral tablet, Vorier 200mg should be taken according to the prescribed schedule and the specified meal spacing in the approved product information.
The exact oral tablet presentation must be verified before publication.
An injectable formulation is a different product and should not be confused with the oral tablet.
Patients should follow the exact prescribed route, dose and schedule.
Do not change, share or discontinue this medicine without the treating professional’s advice.
The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: Vorier 200mg.
- Generic Name: Voriconazole.
- Brand Name: Vorier.
- Strength: 200 mg.
- Therapeutic Category: Antifungal.
- Medicine Class: Triazole Antifungal.
- Indication: Serious invasive fungal infections, including invasive aspergillosis.
- Dosage Form: Oral Tablet — verify packaging.
- Route of Administration: Oral.
The master spreadsheet lists Zydus Cadila as manufacturer/marketer. This attribution and the current pack size, dosage form, labeling, batch details and expiry must be independently verified.
The oral tablet and injectable formulations must not be confused.
Available packaging, batch identification, expiry date and remaining shelf life can vary and should be confirmed by an authorised supplier before any transaction.
A product listing does not confirm current stock, price, availability or eligibility for supply to a particular destination.
Prescription and Patient Safety
Vorier 200mg is a prescription antifungal medicine and should be used under appropriate medical supervision.
Treatment suitability depends on the diagnosis, approved labeling, clinical history and specialist assessment.
Monitoring of liver function, visual effects, photosensitivity and numerous medicine interactions is important.
The exact oral tablet presentation must be verified before publication.
Patients should follow their treating clinician’s instructions and should not independently change or discontinue treatment.
The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal provides medicine information, product identification and enquiry coordination. Where appropriate, Medinglobal may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not manufacture, stock, sell, dispense or prescribe Vorier 200mg through the website.
Any regulated pharmaceutical activity, including prescription verification and lawful supply, remains the responsibility of the relevant independent provider and is subject to applicable laws and regulations.
Availability, prescription requirements, lawful supply routes, supporting documents and destination-country restrictions must be confirmed before any transaction.
Submitting an enquiry does not guarantee supply or availability.
How to Submit a Vorier 200mg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: Vorier 200mg.
- Generic name: Voriconazole.
- Required strength and dosage form.
- Required quantity.
- Destination country.
- Prescription or supporting documentation, where applicable.
Medinglobal may review the submitted details for identification and coordination purposes and, where appropriate, refer the enquiry to an authorised independent provider.
The provider is responsible for its own verification, regulatory checks and any subsequent supply decision.
Frequently Asked Questions
What is Vorier 200mg used for?
Vorier 200mg contains Voriconazole and is associated with the treatment of serious invasive fungal infections, including invasive aspergillosis, subject to the approved product label and medical assessment.
What does Vorier 200mg contain?
It contains Voriconazole 200 mg. The exact composition should be confirmed against the original manufacturer-labelled packaging.
What type of medicine is Vorier 200mg?
It belongs to the systemic antifungal medicine category and is classified as a triazole antifungal.
How is Vorier 200mg administered?
For the verified oral tablet, it is taken according to the prescribed schedule and specified meal spacing. An injectable formulation is a different product.
Does Vorier 200mg require medical supervision?
Yes. Treatment requires appropriate medical supervision, including attention to liver function, visual effects, photosensitivity and medicine interactions.
Can international patients submit a Vorier enquiry through Medinglobal?
International enquiries may be submitted. Any coordination or subsequent supply depends on confirmation by an authorised independent provider and compliance with applicable regulations.
Does Medinglobal sell or dispense Vorier directly?
No. Medinglobal provides product information, identification and enquiry coordination. It does not itself manufacture, sell, dispense or prescribe the medicine through the website.

Reviews
There are no reviews yet.